87 related articles for article (PubMed ID: 1325235)
1. The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia.
Kusumoto K; Mackay KB; McCulloch J
Brain Res; 1992 Mar; 576(1):147-51. PubMed ID: 1325235
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia.
Hayward NJ; McKnight AT; Woodruff GN
Eur J Neurosci; 1993 Jul; 5(7):961-7. PubMed ID: 8281306
[TBL] [Abstract][Full Text] [Related]
3. Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.
Mackay KB; Kusumoto K; Graham DI; McCulloch J
Brain Res; 1993 Aug; 618(2):213-9. PubMed ID: 8397047
[TBL] [Abstract][Full Text] [Related]
4. Effect of the kappa-1 opioid agonist CI-977 on ischemic brain damage and cerebral blood flow after middle cerebral artery occlusion in the rat.
Mackay KB; Kusumoto K; Graham DI; McCulloch J
Brain Res; 1993 Nov; 629(1):10-8. PubMed ID: 8287264
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
Park CK; McCulloch J; Kang JK; Choi CR
Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
[TBL] [Abstract][Full Text] [Related]
6. The relationship between glutamate release and cerebral blood flow after focal cerebral ischaemia in the cat: effect of pretreatment with enadoline (a kappa receptor agonist).
MacKay KB; Patel TR; Galbraith SL; Woodruff GN; McCulloch J
Brain Res; 1996 Mar; 712(2):329-34. PubMed ID: 8814909
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective actions of GR89696, a highly potent and selective kappa-opioid receptor agonist.
Birch PJ; Rogers H; Hayes AG; Hayward NJ; Tyers MB; Scopes DI; Naylor A; Judd DB
Br J Pharmacol; 1991 Jul; 103(3):1819-23. PubMed ID: 1657267
[TBL] [Abstract][Full Text] [Related]
8. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the relationship between ischemic damage and brain swelling in frozen brain slices.
Park CK; Jun SS; Cho SH; Kang JK
Acta Neurochir Suppl; 1997; 70():17-9. PubMed ID: 9416265
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective kappa-opioid receptor agonist BRL 52537 attenuates ischemia-evoked nitric oxide production in vivo in rats.
Goyagi T; Toung TJ; Kirsch JR; Traystman RJ; Koehler RC; Hurn PD; Bhardwaj A
Stroke; 2003 Jun; 34(6):1533-8. PubMed ID: 12738895
[TBL] [Abstract][Full Text] [Related]
11. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
[TBL] [Abstract][Full Text] [Related]
12. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window.
Sydserff SG; Borelli AR; Green AR; Cross AJ
Br J Pharmacol; 2002 Jan; 135(1):103-12. PubMed ID: 11786485
[TBL] [Abstract][Full Text] [Related]
13. Effect of delayed albumin hemodilution on infarction volume and brain edema after transient middle cerebral artery occlusion in rats.
Belayev L; Busto R; Zhao W; Clemens JA; Ginsberg MD
J Neurosurg; 1997 Oct; 87(4):595-601. PubMed ID: 9322848
[TBL] [Abstract][Full Text] [Related]
14. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat.
Park CK; Nehls DG; Graham DI; Teasdale GM; McCulloch J
Ann Neurol; 1988 Oct; 24(4):543-51. PubMed ID: 2853604
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of ischemic brain edema and cerebrovascular injury after ischemic preconditioning in the rat.
Masada T; Hua Y; Xi G; Ennis SR; Keep RF
J Cereb Blood Flow Metab; 2001 Jan; 21(1):22-33. PubMed ID: 11149665
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of recombinant neutrophil inhibitory factor in transient focal cerebral ischaemia in the rat.
Mackay KB; Bailey SJ; King PD; Patel S; Hamilton TC; Campbell CA
Neurodegeneration; 1996 Dec; 5(4):319-23. PubMed ID: 9117543
[TBL] [Abstract][Full Text] [Related]
17. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: a time-course study.
Baker CJ; Onesti ST; Solomon RA
J Neurosurg; 1992 Sep; 77(3):438-44. PubMed ID: 1506891
[TBL] [Abstract][Full Text] [Related]
18. The kappa opioid agonist niravoline decreases brain edema in the mouse middle cerebral artery occlusion model of stroke.
Guéniau C; Oberlander C
J Pharmacol Exp Ther; 1997 Jul; 282(1):1-6. PubMed ID: 9223533
[TBL] [Abstract][Full Text] [Related]
19. The effect of chlormethiazole on neuronal damage in a model of transient focal ischaemia.
Sydserff SG; Cross AJ; West KJ; Green AR
Br J Pharmacol; 1995 Apr; 114(8):1631-5. PubMed ID: 7599933
[TBL] [Abstract][Full Text] [Related]
20. Oedema reduction by levemopamil in focal cerebral ischaemia of spontaneously hypertensive rats studied by magnetic resonance imaging.
Elger B; Seega J; Raschack M
Eur J Pharmacol; 1994 Mar; 254(1-2):65-71. PubMed ID: 8206118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
